Skip to main content

Table 3 Univariate analysis of the prognostic factors for survival

From: Silva cumulative score and its relationship with prognosis in Endocervical adenocarcinoma

clinicopathological characteristics

OS (month)

DFS (month)

mean OS

95%CI

p-value

mean DFS

95%CI

p-value

FIGO stage

 I

86.404

81.673–91.134

0.002

80.687

73.876–87.498

0.022

 II

83.097

73.588–92.605

79.356

68.054–90.659

 III

58.090

47.000–69.181

54.750

42.077–67.423

Silva system

 pattern A

NA

NA

0.205

NA

NA

0.181

 pattern B

NA

NA

NA

NA

 pattern C

NA

NA

NA

NA

DOI

 <1/2

87.784

83.232–92.336

0.008

82.859

75.953–89.764

0.047

 >1/2

77.488

69.949–85.026

72.234

63.135–81.333

SCS grade

 grade I (score 2–3)

NA

NA

0.014

88.348

81.347–95.349

0.024

 grade II (score 4–5)

NA

NA

82.860

72.364–93.357

 grade III (score 6–7)

NA

NA

71.109

61.975–80.244

LVI

 Negative

90.817

86.852–94.782

0.000

84.004

77.212–90.797

0.021

 Positive

72.566

63.005–82.126

69.811

59.064–80.558

LNM

 Negative

87.262

82.714–91.809

0.001

81.841

75.678–88.004

0.007

 Positive

58.090

47.000–69.181

54.750

42.077–67.423